Maharashtra, India

Sunil Suresh Jog

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Indicus Pharma LLC, Usv Private Limited. Active years: 2014.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sunil Suresh Jog: Innovator in Pharmaceutical Compositions

Introduction

Sunil Suresh Jog is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release compositions. His work has the potential to enhance the efficacy of drug delivery systems.

Latest Patents

Sunil Suresh Jog holds a patent for "Modified release pharmaceutical compositions." This patent discloses multiparticulate modified release pharmaceutical compositions that include a first portion with an active ingredient, at least one surfactant, and at least one release modifying agent. The second portion also contains an active ingredient and optionally a release modifying agent. Notably, the active ingredient in the first portion is a calcium channel blocker, and the modified release composition is designed as a multiparticulate tablet.

Career Highlights

Throughout his career, Sunil has worked with reputable companies such as USV Private Limited and Indicus Pharma LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Sunil has collaborated with professionals like Nitin Vadilal Sheth and Sampada Hemant Tupe, which has further enriched his work in the pharmaceutical sector.

Conclusion

Sunil Suresh Jog is a distinguished inventor whose contributions to modified release pharmaceutical compositions are noteworthy. His innovative work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…